Clinical trial · Interventional
Aesthetic Outcomes of Oncoplastic Breast Surgery for Breast Cancer in the Upper Inner Quadrant
Aesthetic Outcomes of Oncoplastic Breast Surgery With a Droplet-Shaped Glandular Flap for Breast Cancer in the Upper Inner Quadrant
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Oncoplastic breast surgery, combining oncological resection with plastic surgical techniques, has emerged as an important surgical strategy to optimize conventional breast-conserving surgery. The upper inner quadrant is one of the most difficult and challenging tumor locations for surgeons to perform oncoplastic breast surgery. There is a pressing need to develop a simple and effective oncoplastic surgical technique to cope with the unfavorable anatomy and location of tumors in the UIQ. Here, we present a new oncoplastic volume displacement technique for UIQ using the DSG flap. This trial was design to estimate the aesthetic outcomes of an oncoplastic technique using a droplet-shaped glandular flap for breast cancer in the upper inner quadrant.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Aesthetic Outcomes | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Oncoplastic Breast Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Oncoplastic technique with a droplet-shaped glandular flap | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Oncoplastic technique with a droplet-shaped glandular flap
- interventionNames
- Procedure: Oncoplastic technique with a droplet-shaped glandular flap
Primary outcomes (1)
- measure
- aesthetic outcomes
- timeFrame
- half a year to one year
- description
- ABNSW system. The total score was 15 points, outcomes were good when it was 11-14, fair when it was 6-10, and poor when it was 0-5.
Secondary outcomes (3)
- measure
- Patients' quality of life
- timeFrame
- half a year to one year
- description
- EORTC QLQ-C30 questionnaire
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Signed the informed consent. * Female aged between 18 and 70 years. * Pathologically diagnosed operable breast cancer. * WHO Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. * Cancer located in the upper inner quadrant; Single tumor or multiple tumors in the same quadrant. * The important organ functions meet the following criteria: * WBC \>=3.0 x 10\^9/L; Neutrophilic granulocytes \>=1.5×10\^9/L; Platelet \>=100 x 10\^9/L; Hb \>=9 g/dL; * Total bilirubin no more than 1.5 times the normal upper limit (ULN); AST and ALT no more than 1.5 times ULN; AKP no more than 2.5 times ULN; * Serum creatinine no more than 1.5 times ULN or Clearance rate of creatinine \>= 60ml/min; * Thyroid stimulating hormone (TSH) \<= ULN (T3, T4 levels need to be detected simultaneously if abnormalities, the patient can be included if T3, T4 levels is normal); * LVEF basement \>= 50%. * Adjust to the criteria of breast conserving surgery. Exclusion Criteria: * Multifocal or multicentric disease. * Tumor localized in the central quadrant or the distance to the nipple \< 2 cm; * Diffused calcifications with fine plemorphic or fine linear or fine-linear branching morphology. * The ratio of tumor to breast \> 20%; * The diameter of tumor is up to 4 cm; * Women in the early or intermediate stage of pregnancy; * Prior history of breast radiation; * Any severe comorbidities, inability to give informed consent or unavailability for follow-up.
References
Publications (0)
Data not yet available